DEAR.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Devices

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
DEAR.STDuearity AB (publ)	$0.02	+0.00%	$3M	—
ASAP.STAsarina Pharma AB (publ)	$0.03	-31.03%	$633959	—
BIOS.STBioservo Technologies AB (publ)	$0.02	-5.88%	$1M	—
BONZUN.STBonzun AB (publ)	$0.01	+0.00%	$7M	—
CLINE-B.STCline Scientific AB (publ)	$0.07	+0.00%	$3M	—
CYXO.STCyxone AB (publ)	$0.02	+0.00%	$7M	—
HEMC.STHemcheck Sweden AB (publ)	$0.23	+26.11%	$9M	—

Source: Financial Modeling Prep · peers by sector/industry

Duearity AB (publ)

Established in Malmö, Sweden, in 2020, Duearity AB (publ) operates in the medical technology sector, specializing in treatments for tinnitus. Their flagship product, Tinearity, is an innovative aid that utilizes a compact sound emitter to produce therapeutic white noise, delivered directly into the user's ear through bone conduction via the skull. Additionally, the company is actively developing Tinearity AI, an artificial intelligence-powered solution intended to empower those affected by tinnitus to effectively control their symptoms.

www.duearity.com

Employees: 2
IPO / List date: May 11, 2021
HQ: SE

Held by traders on TradeandTell

No one on the platform currently holds DEAR.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in DEAR.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded DEAR.ST yet.